Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSphere Medical Holding Regulatory News (SPHR)

  • There is currently no data for SPHR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sphere Medical confirms Proxima compatibility

29 Jun 2017 07:00

RNS Number : 5057J
Sphere Medical Holding plc
29 June 2017
 

29 June 2017

 

Sphere Medical Holding plc

("Sphere", "Sphere Medical" or the "Company")

Sphere Medical confirms compatibility of Proxima™ bedside blood gas monitoring system with leading global patient monitor player

 

~ Sphere enhances point-of-care connectivity functionality of Proxima acute respiratory and metabolic monitoring device in critical care settings ~

 

Cambridge, UK - 29 June 2017 - Sphere Medical Holding plc (AIM: SPHR.L), an innovative point-of-care monitoring and diagnostic devices company, announces that its Proxima™ bedside blood gas monitoring system is now compatible with Philips IntelliVue Patient Monitoring Systems through the Philips IntelliBridge Interface Module.

 

Sphere Medical's Proxima is an acute respiratory and metabolic monitoring system used in critical care settings which supports proactive patient care. It enables rapid and frequent blood gas, glucose and electrolyte measurements directly at the bedside without the caregiver leaving the patient. Philips compatibility means that Proxima's results can be recorded and displayed alongside other critical monitoring information, such as blood pressure, ECG, EEG, respiratory rate, cardiac output and temperature. Such consolidated information gives a comprehensive patient overview, enhancing patient management. With the increasing adoption of electronic data record systems in critical care settings, Philips compatibility will also give Proxima customers a very simple means of integrating their data into electronic medical record systems (EMR).

 

Sphere Medical's latest Proxima 4 system is currently being sold directly into the critical care market in the UK, Germany, The Netherlands and Belgium and via distributors in Italy, Spain and Austria.

 

Commenting on the additional point-of-care connectivity functionality of the Proxima bedside blood gas analyser, Wolfgang Rencken, CEO of Sphere Medical, said: "We are extremely pleased with the confirmation that Proxima is now compatible with Philips IntelliVue patient monitors. Many of our customers use Philips monitoring and data management systems and this connectivity further helps the practical implementation of Proxima as an acute respiratory and metabolic monitoring device in critical care settings. We look forward to offering this enhanced compatibility with our latest Proxima 4 system to hospitals across Europe."

 

- Ends -

 

 

For further information, please contact:

 

Sphere Medical Holding plc

Tel: +44 (0)1223 875 222

Dr Wolfgang Rencken, Chief Executive Officer

Richard Wright, Chief Financial Officer

Panmure Gordon

Tel: +44 (0) 20 7886 2500

Freddy Crossley (Corporate Finance)

Duncan Monteith (Corporate Finance)

Tom Salvesen (Corporate Broking)

Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott

spheremedical@consilium-comms.com

Ivar Milligan

Rosie Phillips

 

Notes for Editors

 

About Sphere Medical (AIM: SPHR.L)

Sphere Medical is an innovative point-of-care medical device company. Its Proxima platform measures blood gases, electrolytes and metabolites at the patient's bedside and aims to improve patient care and reduce health system costs. The device is sold directly to the critical care market via Sphere Medical's sales force in the UK, Germany, The Netherlands and Belgium and via distributors in Italy, Spain and Austria. For further information, please visit www.spheremedical.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALFFVLREITFID
Date   Source Headline
18th Jul 201311:17 amRNSTR-1: Notification of Major Interest in Shares
17th Jul 20135:20 pmRNSTR-1: Notification of Major Interest in Shares
17th Jul 20134:36 pmRNSTR-1: Notification of Major Interest in Shares
17th Jul 20133:14 pmRNSTR-1: Notification of Major Interest in Shares
17th Jul 20138:01 amRNSDirector/PDMR Shareholding
16th Jul 201312:00 pmRNSResult of General Meeting
16th Jul 20137:00 amRNSResult of Open Offer
8th Jul 20137:00 amRNSPositive results from Proxima technology
1st Jul 20137:00 amRNSPosting of Shareholder Circular
28th Jun 20134:08 pmRNS2012 Annual Report & Accounts and Notice of AGM
28th Jun 20131:13 pmRNSFinal Results for the year ended 31 December 2012
28th Jun 20131:04 pmRNSProposed Collaboration Agreement and Fundraising
4th Dec 20122:40 pmRNSTR-1: Notification of Major Interest in Shares
23rd Nov 20127:00 amRNSPositive Results from Pelorus 1500 Study
25th Sep 20129:30 amRNSPresenting at Proactive Investors Investor Forum
20th Sep 20127:00 amRNSInterim Results 2012
29th Aug 20127:00 amRNSNotice of Interim Results
16th Jul 20127:00 amRNSPelorus 1500 IVD Achieves CE Marking
10th Jul 20127:00 amRNSFirst Sales Order from Sorin for CPB Product
21st Jun 20127:00 amRNSSphere Appoints Distributor in Japan
29th May 20122:29 pmRNSResult of Annual General Meeting
21st May 20127:00 amRNSGrant of Options and Directors' Interests
21st May 20127:00 amRNSGrant of Share Options and Directors' Interests
8th May 20127:00 amRNS2011 Annual Report & Accounts and Notice of AGM
22nd Mar 20127:00 amRNSPreliminary Results
24th Feb 20127:00 amRNSNotice of Preliminary Results
8th Feb 20127:00 amRNSImproving Accuracy of Propofol Dosing
5th Jan 20121:13 pmRNSAmended Notice of Interest in Shares
19th Dec 20117:00 amRNSProxima Generation 2 Achieves European CE Marking
13th Dec 20113:51 pmRNSNotification of Major Interest in Shares
23rd Nov 20117:00 amRNSScope Extension to include Manufacturing
22nd Nov 20113:10 pmRNSNotice of Interest in Shares
21st Nov 201112:49 pmRNSNotice of Interest in Shares
21st Nov 20117:00 amRNSNotification of Major Interest in Shares
21st Nov 20117:00 amRNSClinical Trial Success
18th Nov 20118:40 amRNSCompleted Second Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.